Professional Documents
Culture Documents
gov ISRCTN
2017-002248-34
2016-003345-29
2016-001223-31 11847553
2015-005297-37
2015-004527-32
2014-004557-14 47808000
2013-004704-19
2013-004124-11
2012-005500-18
2012-004078-24
2010-022518-16
2010-019810-26
2015-004064-11 32236160
2015-002668-18
2013-002267-25
2012-004511-30
2010-023851-27
2010-022260-12
2009-017098-40 NCT01133886
2009-016873-13
2009-015559-25
2008-002336-15
2007-004298-24 37118456
2007-001657-26
2007-000497-23
2012-005592-13
2009-012509-20 NCT01006538
2004-005101-29
2004-003753-56
2009-010808-28
2013-004708-20
2006-006617-32
Status in
Title EudraCT
FInCH Study: A randomised feasibility study comparing fluoride interventions to
prevent dental decay in older people in care homes. Ongoing
Safety of tenofovir alafenamide (TAF) in patients with a history of tubulopathy on
tenofovir disoproxil fumarate (TDF) Ongoing
Prospective randomised marker-based trial to assess the clinical utility and safety of
biomarker-guided immunosuppression withdrawal in liver transplantation Ongoing
Globifer Forte® Oral Haem and Non-haem Iron Supplementation in Heart Failure: A
Randomised, DoubleBlind, Placebo Controlled, Double Dummy, Part Mechanistic. Ongoing
Double blind randomised multicentre study to assess the effect of local anaesthesia
during vaginal hysterectomy Ongoing
A Phase II trial of broad spectrum antibiotic therapy for early stage chronic lymphocytic
leukaemia. completed
Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Ongoing,
Failure (DEC-MDS) reported early
A novel therapy using recombinant human PTH 1-84 to stimulate bone repair and
enhance fracture healing in the acute Charcot foot: a double blind placebo controlled
phase IV trial Ongoing
Preoperative intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: A
randomized, double-masked, controlled study Ongoing
The Efficacy and Safety of lenalidomide (Revlimed) Monotherapy in Red Blood Cell
Transfusion Dependent Sugjcets with Myelodysplasitc Syndrome Associated with a
DEL (5q) Cytogenic Abnormality Ongoing
Randomised double blind control trial of single dose methotrexate versus expectant Ongoing,
management in women with tubal ectopic pregnancy reported early
Ongoing,
Role of Non-invasive test in detecting fibrosis in chronic hepatitis B patients reported early
A placebo controlled single centre double blind randomised trial to investigate the
efficacy of rifaximin versus placebo in improving systemic inflammation and neutrophil
malfunction in patients with cirrhosis and chronic hepatic encephalopathy Completed
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Ongoing NA NA
Completed
(No pts
recruited) 2/7/2013 Reported
Abandoned
(No pts
recruited) 10/30/2008 Trial Abandoned
Publications
NA
NA
NA
NA
NA
University of York may have a study by same name, exact search brings up a page on website with pubme
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Lancet. 2015 Nov 7;386(10006):1835-44. doi: 10.1016/S0140-6736(15)00126-9. Epub 2015 Sep 3 and Dys
NA
NA
NA
NA
Ultrasound Obstet Gynecol. 2017 Feb;49(2):171-176. doi: 10.1002/uog.17329. Epub 2017 Jan 6
NA
NA
NA
Funder Funding Amount
NIHR
Gilead
Sciences
NIHR-EME grant
King's Health Partners R&D Challenge fund (Guy's and St Thomas' Charity)
Kings College Hospital NHS Founvery hard to find this study at all and very little info on it
Takeda UK Limited
NIHR
Kidney Research UK
Janssen
Cilag
Diabetes UK
NIHR